Hematology and Cardio-Oncology

Cardiovascular issues through blood and consequently the framework that gives research facility esteems with respect to blood, the circulatory framework and gets cardiovascular infections from the Chinese medication and western medication points of view. Cardio-Oncology is to search out a harmony between oncologic adequacy and diminishing adversarial cardiovascular impacts over opportune distribution and broadcasting of exploration. Cardiovascular imaging and transthoracic echocardiography assume a significant part inside the benchmark evaluation and sequential development of cardio-oncology patients. Logical sign in the organization of cardiovascular hitches of onco-hematological patients is uncommon, as these patients have been methodicallly excluded from clinical preliminaries and cutting-edge endorsements depend on master assent. Cardio-onco-hematology which license its case in normal clinical readiness so to advertise the development of nearby multidisciplinary teams, to energize the cardiovascular wellbeing of patients with malignancy.

  • Amyloid cardiomyopathy
  • Echocardiographic
  • Cardiotoxicity
  • Chemotherapy
  • Cancer Genomics
  • Thrombocytopenias
  • Henoch-Schönlein purpura
  • Pediatric hematology/oncology
  • Hematologic critical care

Related Conference of Hematology and Cardio-Oncology

February 19-20, 2024

22nd World Hematology Congress

London, UK

Hematology and Cardio-Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in